← Research library

Antimutagenic Hypoxen activity in vivo

Animal research · 2002

What was studied
C57BL/6 mouse bone-marrow chromosome-aberration assay
Main finding
Simultaneous injected Hypoxen reduced dioxidine-associated genotoxicity by a reported 35% over 24 hours. Five-day oral pretreatment did not reduce damage.

Study data at a glance

Participants or experimental model
C57BL/6 mouse bone-marrow chromosome-aberration assay
Reported results
Simultaneous injected Hypoxen reduced dioxidine-associated genotoxicity by a reported 35% over 24 hours. Five-day oral pretreatment did not reduce damage.
Study limitations and source details

Study limitations

  • Route- and timing-dependent results; the oral negative finding must be retained.
  • A mouse mutagen assay does not establish protection against industrial gases, benzene or cancer.

Source details

Journal article

Indexed or publisher abstract reviewed; full methods and risk of bias not appraised.

Abstract reviewed

Sources checked

Citation

Animal / experimentalEnglish abstract

O. A. Karpova, L. V. Mikhina, A. A. Denisov, M. K. Kuzmich. Antimutagenic Hypoxen activity in vivo Experimental and Clinical Pharmacology. 65(3):54–56

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards